Nu-Med Plus (NUMD) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 13.22% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.93% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.89% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.89% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.35% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 14.29% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.56% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.46% |
| 10 | Nu-Med Plus | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -99.55% |
| Mar 31, 2022 | -97.21% |
| Dec 31, 2021 | -80.52% |
| Sep 30, 2021 | -65.58% |
| Jun 30, 2021 | -56.34% |
| Mar 31, 2021 | -55.92% |
| Dec 31, 2020 | -50.35% |
| Sep 30, 2020 | -46.03% |
| Jun 30, 2020 | -41.45% |
| Mar 31, 2020 | -38.28% |
| Dec 31, 2019 | -36.33% |
| Sep 30, 2019 | -34.77% |
| Jun 30, 2019 | -32.96% |
| Mar 31, 2019 | -23.08% |
| Dec 31, 2018 | -20.89% |
| Sep 30, 2018 | -19.02% |
| Jun 30, 2018 | -17.76% |
| Mar 31, 2018 | 101.57% |
| Dec 31, 2017 | 101.49% |
| Sep 30, 2017 | 101.43% |
| Jun 30, 2017 | 101.37% |
| Mar 31, 2017 | -7.75% |
| Dec 31, 2016 | -23.64% |
| Sep 30, 2016 | -22.16% |
| Jun 30, 2016 | -21.14% |
| Mar 31, 2016 | -35.15% |
| Dec 31, 2015 | -19.13% |
| Sep 30, 2015 | -14.52% |
| Jun 30, 2015 | -15.02% |
| Mar 31, 2015 | -14.26% |
| Dec 31, 2014 | -13.56% |
| Sep 30, 2014 | 119.17% |
| Jun 30, 2014 | 146.75% |
| Mar 31, 2014 | 146.79% |
| Dec 31, 2013 | 146.83% |
| Mar 31, 2013 | -3.99% |
| Dec 31, 2012 | 3,168.47% |